Hypera S.A. (BVMF:HYPE3)
Brazil
· Delayed Price · Currency is BRL 21.02
+0.46 (2.24%)
Apr 23, 2025, 5:07 PM GMT-3
Hypera Revenue
Hypera had revenue of 1.08B BRL in the quarter ending March 31, 2025, a decrease of -40.83%. This brings the company's revenue in the last twelve months to 6.70B, down -16.74% year-over-year. In the year 2024, Hypera had annual revenue of 7.44B, down -5.97%.
Revenue (ttm)
6.70B
Revenue Growth
-16.74%
P/S Ratio
1.99
Revenue / Employee
638.94K
Employees
10,481
Market Cap
13.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.44B | -472.19M | -5.97% |
| Dec 31, 2023 | 7.91B | 368.30M | 4.88% |
| Dec 31, 2022 | 7.55B | 1.61B | 27.10% |
| Dec 31, 2021 | 5.94B | 1.85B | 45.21% |
| Dec 31, 2020 | 4.09B | 794.12M | 24.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 50.57B |
| Raia Drogasil | 38.86B |
| Fleury | 7.68B |
| Odontoprev | 2.43B |
| Oncoclínicas do Brasil Serviços Médicos | 6.23B |
| Diagnósticos da América | 15.32B |
| Blau Farmacêutica | 1.75B |
| Empreendimentos Pague Menos | 12.64B |